BridgeMD
New treatment option for Tuberculosis
Official title The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
ClinicalTrials.gov ID: NCT06593080
What this study is testing
- What it's testing
- The Decide-TB project aims to generate evidence for the implementation of a comprehensive Treatment Decision Algorithms (TDA) based approach for TB in children living in high TB burden and resource-limited countries, at District Hospital (DH) and Primary Health Centre (PHC) levels, and to facilitate the integration of this evidence within practices and policies. This programmatic pilot led by the National TB Programs (NTP) will test a TDA-based approach integrating TB screening, diagnosis, treatment decision-making, and disease severity assessment for shorter treatment eligibility, for use at a lower level of healthcare.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 14. Healthy volunteers may be eligible.
You may be able to join if
- The how well it works assessment will be conducted using aggregated or individual data from direct beneficiaries of the intervention:
- All sick children aged below 15 years entering the selected health facilities (DH and PHC) at either outpatient (OPD) or inpatient (IPD) departments...
- Children with presumptive TB. The WHO definition of presumptive TB will be used, as defined in the 2022 WHO Operational Handbook, namely: children...
You likely can't join if
- There will be no exclusion criteria for the programmatic pilot: all children will be offered the intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Chingola, Copperbelt, Zambia
- Luanshya, Copperbelt, Zambia
- Chirundu, Southern Province, Zambia
- Kalomo, Southern Province, Zambia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, up to 14 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chingola, Copperbelt, Zambia; Luanshya, Copperbelt, Zambia; Chirundu, Southern Province, Zambia; Kalomo, Southern Province, Zambia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.